| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |